Outcomes Associated with Sodium-Glucose Cotransporter-2 Inhibitor Use in Acute Heart Failure Hospitalizations Complicated by AKI

KEY POINTS: In a multicenter retrospective cohort study of adults hospitalized with acute heart failure, exposure to sodium-glucose cotransporter-2 inhibitor during AKI was associated with lower risk of 30-day mortality. Exposure to sodium-glucose cotransporter-2 inhibitor during acute heart failure...

Descripción completa

Detalles Bibliográficos
Autores principales: Aklilu, Abinet M., Kumar, Sanchit, Yamamoto, Yu, Moledina, Dennis G., Sinha, Frederick, Testani, Jeffrey M., Wilson, F. Perry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Nephrology 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615381/
https://www.ncbi.nlm.nih.gov/pubmed/37644648
http://dx.doi.org/10.34067/KID.0000000000000250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615381/
https://www.ncbi.nlm.nih.gov/pubmed/37644648
http://dx.doi.org/10.34067/KID.0000000000000250

Ejemplares similares